2nd June 2010
Novotech joins Medidata programme
Having joined the programme Novotech will use the Medidata Rave electronic data capture (EDC) and clinical data management (CDM) systems to streamline its trials. Asia Pacific-focused Novotech conducts Phase I to III trials in nine countries across a range of therapeutic areas.
Novotech believes Medidata’s software will help it handle large, complex, global clinical trials. Alek Safarian, CEO of Novotech, added that he expects the system to improve communication with clients based in North America and Europe.